Exchange: NYSEMkt·Updated 07:56 PM EST

NRXS News

News
all
press releases
Doximity (DOCS) Beats Q2 Earnings and Revenue Estimates
Doximity (DOCS) delivered earnings and revenue surprises of +5.88% and +2.27%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Doximity (DOCS) Beats Q2 Earnings and Revenue Estimates
Doximity (DOCS) delivered earnings and revenue surprises of +5.88% and +2.27%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
NRXS is benefiting from stronger IB-Stim volumes, broader reimbursement and VA access, but incomplete payer coverage and cash needs remain challenges.
Zacks
KODK and NRXS are worth watching for their growth.
Zacks
NeurAxis delivers record second-quarter 2026 revenues as stronger IB-Stim demand, higher pricing and an improved reimbursement mix lift gross margin.
Zacks
NRXS' first-quarter 2026 results show surging revenue and expanding gross margin as reimbursement improves under the Category I CPT code.
Zacks
Alphabet, Walmart and Micron lead Zacks research as AI growth, retail strength and memory demand drive performance, while risks linger.
Zacks
Alphabet rides AI-driven growth across Search, Cloud and subscriptions, but rising spending, debt and legal risks temper near-term flexibility.
Zacks
NRXS witnesses strong revenue growth and expanding coverage in fourth-quarter 2025, but rising costs and commercialization investments weigh on profitability.
Zacks
Meta Platforms leads today???s Zacks Research Daily as AI-driven engagement and ad demand fuel growth, even as heavy AI investments raise monetization concerns.
Zacks
Meta Platforms leads today's Zacks Research Daily as analysts highlight strong user growth, heavier AI investment and lingering concerns around monetization.
Zacks

Advertisement|Remove ads.